U.S. Stem Cell, Inc.

USRM·OTC Markets OTCPK·Healthcare
Compare
0.00010.0000 (0.00%)today
At close: Nov 3, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.0001
Open0.0001
Day range—
52-week range0.00000.0002
Off day high0.00%
Off 52-week high−50.00%
Volume60.00K
Avg. volume (3M)58.27K
Market cap64.15K
EPS (TTM)0.000000
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)-107.25
Shares outstanding641.51M
Short interest—
Earnings dateMar 31, 2022
Analyst target—
Profit margin0.00%

Against its peers

Compare in full ›
USRM BRTX BCDA CELZ MESO CYP.AX
Market cap 64.15K 2.09M 13.82M 4.95M 1.86B 4.38M
P/E (TTM) — — — — — —
Forward P/E — -0.1 -1.6 -0.7 31.4 -0.2
Price/book 0.0 0.6 5.1 0.5 3.3 -6.5
Dividend yield — — — — — —
1-year change 0.00% −94.93% −28.91% −78.05% −4.29% −94.47%
Today 0.00% +2.03% −0.92% −3.21% −3.25% 0.00%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

Latest news

All USRM news ›
@PRNewswire·Positive

Top U.S. Stem-Cell Provider Named as Celebrity Demand Soars

/PRNewswire/ -- As celebrities like Kim Kardashian and Khloé Kardashian travel overseas for unregulated stem-cell procedures, Americans are asking why safe,... Innovations Stem Cell Center offers safe, standardized, and affordable…

From the 4Search news index, newest first.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance